EFFECT OF PTH AND 1,25(OH)2D3 ON RENAL 25-OH-D3 METABOLISM, ADENYLATE-CYCLASE ACTIVITY, AND PROTEIN-KINASE

被引：0
|
作者：
ARMBRECHT, HJ [1 ]
WONGSURAWAT, N [1 ]
ZENSER, TV [1 ]
DAVIS, BB [1 ]
机构：
[1] VET ADM MED CTR,GRECC,ST LOUIS,MO 63125
来源：
CALCIFIED TISSUE INTERNATIONAL | 1983年 / 35卷 / 4-5期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：689 / 689
页数：1
相关论文
共 50 条
  • [31] 24,25(OH)2D3 ENHANCES THE CALCEMIC EFFECT OF 1,25(OH)2D3 IN INTACT AND PTX RATS
    WALD, H
    TRAVES, Y
    POPOVTZER, MM
    BONE, 1986, 7 (05) : 414 - 414
  • [32] EFFECT OF VITAMIN-D3, 1,25(OH)2D3 AND ZINC ON BONE METABOLISM
    SOARES, JH
    SHERMAN, SS
    SINHA, R
    SMITH, JC
    FEDERATION PROCEEDINGS, 1985, 44 (04) : 883 - 883
  • [33] Higher levels of 25(OH)D2 and 1,25(OH)2D2 are associated with lower levels of 25(OH)D3 and 1,25(OH)2D3 in older men
    Swanson, Christine
    Nielson, Carrie
    Shrestha, Smriti
    Cummings, Steven
    Barrett-Connor, Elizabeth
    Jans, Ivo
    Boonen, Steven
    Bouillon, Roger
    Vanderschueren, Dirk
    Orwoll, Eric
    JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28
  • [34] FORSKOLIN INCREASES RENAL 1,25(OH)2D3 PRODUCTION AND DECREASES 24,25(OH)2D3 PRODUCTION INVITRO
    ARMBRECHT, HJ
    FORTE, LR
    WONGSURAWAT, N
    ZENSER, TV
    DAVIS, BB
    CLINICAL RESEARCH, 1983, 31 (02): : A380 - A380
  • [35] TREATMENT OF RENAL OSTEODYSTROPHY (ROD) WITH 25-OHD3 AND 1,25 (OH)2D3 - SYNERGIC EFFECT UNRELATED TO 24,25(OH)2D3 SYNTHESIS
    COEN, G
    GALLUCCI, MT
    BONUCCI, E
    BALLANTI, P
    BIANCHI, AR
    MATTEUCCI, MC
    PICCA, S
    BIANCHINI, G
    MAZZAFERRO, S
    CINOTTI, GA
    CASCIANI, CU
    KIDNEY INTERNATIONAL, 1982, 22 (01) : 96 - 96
  • [36] SYNERGIC EFFECT OF 250HD3 AND 1,25(OH)2D3 IN RENAL OSTEODYSTROPHY IS UNRELATED TO 24,25(OH)2D3 LEVELS
    COEN, G
    GALLUCCI, T
    BONUCCI, E
    BALLANTI, P
    MATTEUCCI, MC
    BIANCHI, AR
    BIANCHINI, G
    PICCA, S
    CINOTTI, GA
    CASCIANI, CU
    ARTIFICIAL ORGANS, 1981, 5 (02) : 193 - 193
  • [37] 1,25(OH)2D3 - A NOVEL IMMUNOREGULATOR
    MANOLAGAS, SC
    TSOUKAS, CD
    PROVVEDINI, DM
    DEFTOS, LJ
    CALCIFIED TISSUE INTERNATIONAL, 1984, 36 (04) : 519 - 519
  • [38] THERAPEUTIC EXPERIENCES WITH 25-OH-D3, 1ALPHA-OH-D3 AND 1,25-(OH)2-D3
    KIND, HP
    WERDER, E
    FANCONI, A
    PRADER, A
    HELVETICA PAEDIATRICA ACTA, 1975, : 17 - 17
  • [39] Levels of 1,25(OH)2D3 for patients with pulmonary tuberculosis and correlations of 1,25(OH)2D3 with the clinical features of TB
    Gao, Wei-Wei
    Wang, Yu
    Zhang, Xiang-Rong
    Yin, Chun-Yang
    Hu, Chun-Mei
    Tian, Man
    Wang, Hong-Wei
    Zhang, Xia
    JOURNAL OF THORACIC DISEASE, 2014, 6 (06) : 760 - 764
  • [40] INCREASED CLEARANCE OF 1,25(OH)2D3 AND TISSUE-SPECIFIC RESPONSIVENESS TO 1,25(OH)2D3 IN DIABETIC RATS
    VERHAEGHE, J
    SUIKER, AMH
    VANBREE, R
    VANHERCK, E
    JANS, I
    VISSER, WJ
    THOMASSET, M
    ALLEWAERT, K
    BOUILLON, R
    AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 265 (02): : E215 - E223
12345